Nurse Practitioner, Family · Brooklyn, NY
NPI
1962823732
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2727 Ocean Pkwy Ste L1
Brooklyn, NY, 11235
Phone (917) 204-6434
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
5,238 services
Medicare patients, 2024
302
Average age 77
Drug cost, 2024
$435K
2,693 prescriptions
Company payments, 2025
$1,487
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Helen Chernovets-Vergilis was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 2,400 times for 18 patients. In total Helen Chernovets-Vergilis billed 5,238 services in 32 codes, and Medicare paid $108K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2,400 | 18 | $1.30 | $3,115 |
| 17003 Destruction Skin Lesion | Office | 937 | 91 | $5.14 | $4,820 |
| 99213 Office E&M - Established | Office | 355 | 210 | $66.04 | $23K |
| 17110 Destruction Skin Lesion | Office | 217 | 131 | $85.52 | $19K |
| 11102 Skin Biopsy | Office | 171 | 137 | $56.46 | $9,655 |
| 17000 Destruction Skin Lesion | Office | 145 | 100 | $34.86 | $5,054 |
| 17004 Destruction Skin Lesion | Office | 100 | 62 | $123.63 | $12K |
| 99203 Office E&M - New | Office | 80 | 80 | $79.90 | $6,392 |
| 99214 Office E&M - Established | Office | 78 | 66 | $91.44 | $7,132 |
| 11103 Skin Biopsy | Office | 69 | 55 | $39.42 | $2,720 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 53 | 42 | $0.73 | $38.7 |
| 11900 Skin | Office | 50 | 40 | $31.60 | $1,580 |
| 96573 Skin | Office | 25 | 19 | $179.71 | $4,493 |
| 99204 Office E&M - New | Office | 18 | 18 | $129.43 | $2,330 |
| 99212 Office E&M - Established | Office | 15 | 15 | $38.40 | $576 |
By year: 2022 $1.4M for 17,269 services; 2023 $563K for 18,877 services; 2024 $108K for 5,238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Helen Chernovets-Vergilis prescribed most often to Medicare patients was Ketoconazole, with 370 prescriptions and refills. In total Helen Chernovets-Vergilis wrote 2,693 Medicare prescriptions that cost $435K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 370 | 391 | 156 | $5,508 |
| Mupirocin Generic | 253 | 256 | 213 | $1,627 |
| Metronidazole Generic | 126 | 134 | 80 | $6,662 |
| Triamcinolone Acetonide Generic | 125 | 133 | 86 | $1,479 |
| Clobetasol Propionate Generic | 125 | 126 | 66 | $7,591 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 103 | 113 | 66 | $2,179 |
| Silver Sulfadiazine Generic | 102 | 117 | 76 | $1,923 |
| Gentamicin Sulfate Generic | 101 | 105 | 70 | $3,817 |
| Clindamycin Phosphate Generic | 97 | 101 | 56 | $6,874 |
| Ammonium Lactate Generic | 91 | 105 | 51 | $1,575 |
| Halobetasol Propionate Generic | 73 | 75 | 47 | $4,790 |
| Tacrolimus Generic | 71 | 86 | 46 | $9,408 |
| Opzelura Ruxolitinib Phosphate | 69 | 70 | 34 | $135K |
| Calcipotriene Generic | 66 | 66 | 34 | $11K |
| Betamethasone Valerate Generic | 64 | 66 | 31 | $12K |
Brand drugs: 476 claims; generic drugs: 2,217 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Helen Chernovets-Vergilis $1,487 ($1,487 in general payments such as food, travel and fees) from 9 companies. The largest payer was Incyte Corporation with $636.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 13 | $636 |
| Organon LLC OGN | 4 | $169 |
| LEO Pharma Inc. | 2 | $158 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $152 |
| Genzyme Corporation SNY | 4 | $145 |
| Pfizer Inc. PFE | 2 | $139 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $40.15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30.73 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $16.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.